SEC Company Response from Sonoma Pharmaceuticals, Inc. (SNOA) (CIK 0001367083) (SNOA) — Jan 22, 2007
Sonoma Pharmaceuticals, Inc. (SNOA) (CIK 0001367083)
Date: Jan. 22, 2007 · CIK: 0001367083 · Accession: 0000950134-07-000983
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-135584
Letter
corresp1
OCULUS INNOVATIVE SCIENCES, INC.
1129 N. McDowell Blvd.
Petaluma, California 94954
January 22, 2007
VIA FACSIMILE AND ELECTRONIC SUBMISSION
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
Oculus Innovative Sciences, Inc. — Registration Statement — Form S-1
Registration Number: 333-135584
Ladies and Gentlemen:
Pursuant to Rule 461 of Regulation C under the Securities Act of 1933, as amended, Oculus Innovative Sciences, Inc. (the “Registrant”) hereby requests that the effective date of the above-captioned registration statement on Form S-1 (as amended, the “Registration Statement”), relating to the registration of 4,025,000 shares of the Registrant’s Common Stock (including 525,000 shares subject to the underwriters’ over-allotment option), be accelerated so that it will be declared effective at 4:30 p.m., Eastern Time, on January 24, 2007 or as soon thereafter as may be practicable.
The Registrant acknowledges that should the Securities and Exchange Commission (the “Commission”) or the Commission’s staff (the “Staff”), acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement. The Registrant also acknowledges that the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filings and the Registrant may not assert Staff comments, the comment process in general or this declaration of effectiveness by the Staff as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. The Registrant understands that the Staff will consider this request as confirmation by the Registrant of its awareness of its responsibilities under the federal securities laws as they relate to the offering of the securities covered by the Registration Statement.
Sincerely,
Oculus Innovative Sciences, Inc.
Show Raw Text
CORRESP
1
filename1.htm
corresp1
OCULUS INNOVATIVE SCIENCES, INC.
1129 N. McDowell Blvd.
Petaluma, California 94954
January 22, 2007
VIA FACSIMILE AND ELECTRONIC SUBMISSION
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
Oculus Innovative Sciences, Inc. — Registration Statement — Form S-1
Registration Number: 333-135584
Ladies and Gentlemen:
Pursuant to Rule 461 of Regulation C under the Securities Act of 1933, as amended, Oculus
Innovative Sciences, Inc. (the “Registrant”) hereby requests that the effective date of the
above-captioned registration statement on Form S-1 (as amended, the “Registration Statement”),
relating to the registration of 4,025,000 shares of the Registrant’s Common Stock (including
525,000 shares subject to the underwriters’ over-allotment option), be accelerated so that it will
be declared effective at 4:30 p.m., Eastern Time, on January 24,
2007 or as soon thereafter as may
be practicable.
The Registrant acknowledges that should the Securities and Exchange Commission (the
“Commission”) or the Commission’s staff (the “Staff”), acting pursuant to delegated authority,
declare the Registration Statement effective, it does not foreclose the Commission from taking any
action with respect to the Registration Statement. The Registrant also acknowledges that the
action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the
Registration Statement effective, does not relieve the Registrant from its full responsibility for
the adequacy and accuracy of the disclosure in the filings and the Registrant may not assert Staff
comments, the comment process in general or this declaration of effectiveness by the Staff as a
defense in any proceeding initiated by the Commission or any person under the federal securities
laws of the United States. The Registrant understands that the Staff will consider this request as
confirmation by the Registrant of its awareness of its responsibilities under the federal
securities laws as they relate to the offering of the securities covered by the Registration
Statement.
Sincerely,
Oculus Innovative Sciences, Inc.
By:
/s/ Robert E. Miller
Robert E. Miller
Chief Financial Officer
cc: Sylvia K. Burks, Esq.